PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19
/PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for drug discovery, today announced that it has received a grant of £100k...
Source: prnewswire.co.uk